These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39118107)

  • 1. Uncovering the hidden socioeconomic impact of juvenile idiopathic arthritis and paving the way for other rare childhood diseases: an international, cross-disciplinary, patient-centered approach (PAVE Consortium).
    Marshall DA; Gerber B; Currie GR; Antón J; De Somer L; Dey M; Egert T; Egert Y; Henan L; Klotsche J; Mifsut LM; Minden K; Normand C; Porte D; Saurenmann RK; Swart JF; Uziel Y; Wilson J; Wouters C; Ziv A; Benseler SM;
    Pediatr Rheumatol Online J; 2024 Aug; 22(1):74. PubMed ID: 39118107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
    BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
    Kuhlmann A; Schmidt T; Treskova M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():79-87. PubMed ID: 27086322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership.
    McErlane F; Foster HE; Armitt G; Bailey K; Cobb J; Davidson JE; Douglas S; Fell A; Friswell M; Pilkington C; Strike H; Smith N; Thomson W; Cleary G
    Rheumatology (Oxford); 2018 Jan; 57(1):140-151. PubMed ID: 29069424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database.
    Minden K; Niewerth M; Listing J; Möbius D; Thon A; Ganser G; Ermisch-Omran B; Zink A
    Clin Exp Rheumatol; 2009; 27(5):863-9. PubMed ID: 19917175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review.
    Kip MMA; Currie G; Marshall DA; Grazziotin Lago L; Twilt M; Vastert SJ; Swart JF; Wulffraat N; Yeung RSM; Benseler SM; IJzerman MJ;
    Pediatr Rheumatol Online J; 2019 May; 17(1):20. PubMed ID: 31060557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
    Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW;
    Trials; 2014 Jan; 15():14. PubMed ID: 24405833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.
    Antón J; Moreno Ruzafa E; Lopez Corbeto M; Bou R; Sánchez Manubens J; Carriquí Arenas S; Calzada Hernández J; Bittermann V; Estepa Guillén C; Mosquera Angarita J; Rodríguez Díez L; Iglesias E; Marti Masanet M; Lopez Montesinos B; González Fernández MI; de Lossada A; Peral C; Valderrama M; Llevat N; Montoro Álvarez M; Calvo Penadés I
    J Health Econ Outcomes Res; 2023; 10(2):141-149. PubMed ID: 38145114
    [No Abstract]   [Full Text] [Related]  

  • 12. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
    McMahan R; Balfe LM; Greene L
    J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.
    Jones AP; Clayton D; Nkhoma G; Sherratt FC; Peak M; Stones SR; Roper L; Young B; McErlane F; Moitt T; Ramanan AV; Foster HE; Williamson PR; Deepak S; Beresford MW; Baildam EM
    Health Technol Assess; 2020 Jul; 24(36):1-152. PubMed ID: 32758350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication.
    Gidman W; Meacock R; Symmons D
    Curr Rheumatol Rep; 2015 May; 17(5):31. PubMed ID: 25874347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
    Ramanan AV; Guly CM; Keller SY; Schlichting DE; de Bono S; Liao R; Quartier P
    Trials; 2021 Oct; 22(1):689. PubMed ID: 34627340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the Management of Uveitis Associated With Juvenile Idiopathic Arthritis: The Czech and Slovak adaptation of SHARE Initiative.
    Malcová H; Dallos T; Bouchalova K; Brejchová I; Brichová M; Bušányová B; Fabianová J; Fráňová J; Furdová A; Jarošová K; Kobrová K; Kostolná B; Košková E; Lokaj M; Macků M; Melocíková J; Michaličková M; Minxová L; Moravčíková D; Němcová D; Pískovský T; Říhová E; Schüller M; Skalická E; Svozílková P; Tomčíková D; Vargová V; Vrtíková E; Doležalová P; Heissigerová J
    Cesk Slov Oftalmol; 2020; 76(4):1-15. PubMed ID: 33086847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis.
    Toupin-April K; Gaboury I; Proulx L; Huber AM; Duffy CM; Morgan EM; Li LC; Stringer E; Connelly M; Weiss JE; Gibbon M; Sachs H; Sivakumar A; Sirois A; Sirotich E; Trehan N; Abrahams N; Cohen JS; Cavallo S; Hindi TE; Ragusa M; Légaré F; Brinkman WB; Fortin PR; Décary S; Lee R; Gmuca S; Paterson G; Tugwell P; Stinson JN
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):74. PubMed ID: 37491246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
    Barber CEH; Twilt M; Pham T; Currie GR; Benseler S; Yeung RSM; Batthish M; Blanchette N; Guzman J; Lang B; LeBlanc C; Levy DM; O'Brien C; Schmeling H; Soon G; Spiegel L; Whitney K; Marshall DA
    Arthritis Res Ther; 2020 Mar; 22(1):53. PubMed ID: 32192528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis.
    Epps H; Ginnelly L; Utley M; Southwood T; Gallivan S; Sculpher M; Woo P
    Health Technol Assess; 2005 Oct; 9(39):iii-iv, ix-x, 1-59. PubMed ID: 16181565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing juvenile idiopathic arthritis within the context of their life: What we learnt from children and youth living with juvenile idiopathic arthritis and their parents.
    Currie GR; Kennedy BL; S M B; R S M Y; J F S; S J V; N M W; M M A K; MacKean G; Marshall DA
    Musculoskeletal Care; 2023 Dec; 21(4):1248-1260. PubMed ID: 37596866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.